用混合分子准多巴胺通路:癌症治疗的新兴前景
Piotr Koch1, Natalia Pielaszkiewicz1, Krystian Małek2
1Institute of Outcomes Research, Maria Sklodowska-Curie Medical Academy in Warsaw 03-411 Warsaw, Poland.
结合多巴胺 (DA) 调节和其他策略的新型混合疗法显示出精确的细胞调节和向药物输送的前景. 需要进一步的研究来克服这些先进的DA路径结构的临床翻译障碍.
科学领域:
- 生物化学和分子生物学
- 药理学和治疗学 药理学和治疗学
- 纳米医学是一种纳米医学.
背景情况:
- 多巴胺 (DA) 信号影响关键的细胞过程,如生长,生存和受体信号.
- 新兴的治疗策略将DA调制与受体共同向和向药物递送相结合.
研究的目的:
- 审查针对DA路径的混合结构的进展.
- 探索这些混合系统背后的机械逻辑.
- 为了确定临床开发的生物和翻译挑战.
主要方法:
- 对DA路径准混合构造的当前文献的审查.
- 分析各种分子格式,包括合体和DA功能化纳米材料.
- 检查临床前证据和潜在的治疗益处.
主要成果:
- 混合构造表明了提高药理学精度和减少目标外影响的潜力.
- 多功能系统包括合体和DA纳米材料.
- 临床前数据表明,细胞内积累得到改善.
结论:
- 混合治疗平台在DA相关的信号调制中提供了更高的精度.
- 临床应用必须解决重要的生物学和转化障碍.
- 进一步开发对于实现这些先进结构的治疗潜力至关重要.
更多相关视频
06:19Author Spotlight: Exploring the Role of Ion Channels in Cancer: Characterization and Potential Treatment Approaches
Published on: June 16, 2023
14:20Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
相关概念视频
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Drugs that Stabilize Microtubules
Treatment Resistant Cancers
